Pharmaco-therapeutic challenges in cancer biology with focus on the immune- system related risk factors.

doi:10.2174/1381612820666140826154147

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Back to search

Article

Pharmaco-therapeutic challenges in cancer biology with focus on the immune- system related risk factors.

Current pharmaceutical design - 1 Jan 2014

Dembic Zlatko

Abstract excerpt

Over the past, progress has always been achieved in therapy of various human diseases with the introduction of novel methodologies from basic to clinical research. Recent advances in techniques, especially DNA sequencing and methylation analyses, faster miniaturized proteomics and live cellular stainings, are opening a new era in cancer research. Perhaps the difference this time can be envisaged as the beginning...

Topics

DNA, Neoplasm
Humans
Mutation
Neoplasms
Risk Factors

Source

Open in PubMed

Identifiers

PMID: 25341937
DOI: 10.2174/1381612820666140826154147

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 30 Aug 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

discussions

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics